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ABSTRACT: A novel neutral iridium carbene complex Ir(κC,O-L1)(COD) (1) [where COD = cyclooctadiene and L1 = 3-(2-
methylene-4-nitrophenolate)-1-(2,4,6-trimethylphenyl) imidazolylidene] with a pendant alkoxide ligand has been prepared and 
characterized. It contains a strong Ir-O bond and X-ray analysis reveals a distorted square planar structure. NMR spectroscopy re-
veals dynamic solution state behavior commensurate with rapid seven-membered ring flipping. In CD2Cl2 solution, under hydrogen 
at low temperature, this complex dominates although it exists in equilibrium with a reactive iridium dihydride cyclooctadiene com-
plex. 1 reacts with pyridine and H2 to form neutral Ir(H)2(κC,O-L1)(py)2 which also exists in two conformers that differ according 
to the orientation of the seven-membered metallocycle and whilst its Ir-O bond remains intact, the complex undergoes both pyridine 
and H2 exchange. As a consequence, when placed under parahydrogen, efficient polarization transfer catalysis (PTC) is observed 
via the Signal Amplification By Reversible Exchange (SABRE) approach. Due to the neutral character of this catalyst, good hy-
perpolarization activity is shown in a wide range of solvents for a number of substrates. These observations reflect a dramatic im-
provement in solvent tolerance of SABRE over that reported for the best PTC precursor IrCl(IMes)(COD). For THF, the associated 
1H NMR signal enhancement for the ortho proton signal of pyridine shows an increase of 600-fold at 298 K. The level of signal 
enhancement can be increased further through warming or varying the magnetic field experienced by the sample at the point of 
catalytic magnetization transfer. 
INTRODUCTION  
The underlying sensitivity problem in NMR has led to the 
development and utilization of hyperpolarization methods to 
address this issue.1-3 ParaHydrogen Induced Polarization4 
(PHIP) is one such method, which produces non-Boltzmann 
spin populations by the incorporation of parahydrogen (p-H2), 
a nuclear singlet, into unsaturated molecules.5, 6 This chemical 
transformation results in increased signal intensity in the cor-
responding NMR spectra of reaction product nuclei originat-
ing from, or coupled to, those that were p-H2 derived nuclei.
7, 8 
Unlike classical PHIP methods, SABRE (Signal Amplifica-
tion By Reversible Exchange)9 does not involve incorporation 
of p-H2 in to the analyte that is to be polarized. Polarization is 
instead transferred via a J-coupling that exists between hy-
dride ligands that are derived from p-H2 and those of the spin-
½ analyte nuclei in the polarization transfer catalyst.9 These 
catalysts most commonly take the form of cationic iridium 
complexes, which possess either phosphine10-13 or N-
heterocyclic carbene (NHC) ligands.14, 15 One of the most suc-
cessful catalysts to date is based upon 
[Ir(H)2(IMes)(analyte)3]Cl and it contains magnetically in-
equivalent but chemically equivalent hydride ligands.15 This 
complex has proved active for a wide range of analytes which 
include pyridine,15, 16 nicotinamide,17-19 isoniazid,20 pyra-
zinamide,20 pyrazole10 and acetonitrile.13 The magnetic field 
experienced by the catalyst at the point of polarization transfer 
is instrumental in determining the amplitude and identity of 
the created magnetic states.18 The use of NHC ligands in the 
catalyst dramatically increased the enhancement levels relative 
to those with PCy3.
14, 15, 20, 21 These charged systems contain 
three analyte molecules and are efficient SABRE catalysts in 
polar solvents such as methanol with benzene being less effec-
tive. In this class of catalyst, SABRE transfer proceeds into 
the two analyte molecules that are trans to hydride ligands. It 
is ligand exchange, a secondary process, which results in visi-
ble hyperpolarization in the analyte molecule in solution. 
An alternative catalyst system has been reported that is 
based on [Ir(H)2(IMes)(PCy3)(analyte)2]Cl.
13 Now the exem-
plified analytes are pyridine and acetonitrile. The mixed ana-
lyte containing catalyst, 
[Ir(H)2(IMes)(PCy3)(pyridine)(CH3CN)]Cl, which is also 
charged, proved most effective for SABRE even though it 
contains a pair of chemically and magnetically inequivalent 
hydride ligands. These results confirmed that it is possible to 
block the two axial coordination sites in the SABRE catalyst 
with non-labile ligands without suppressing activity, whilst 
retaining a charged system. Species such as 
[Ir(H)2(IMes)(PCy3)(pyridine)2]Cl with magnetically inequiva-
lent but chemically equivalent hydride ligands, whilst being 
directly related to [Ir(H)2(IMes)(analyte)3]Cl, proved less ef-
fective due to poor ligand exchange. Herein we present data 
dealing with the use of a neutral iridium catalyst containing a 
cis-spanning bidentate NHC to mediate polarization transfer 
from p-H2 to pyridine and nicotinamide. The use of the chelate 
effect to promote and control catalysis is well exemplified by 
phosphines,22 bipyridyl,23 pincer24, 25 and pincer carbene lig-
ands.26-29 We seek to retain a carbene functionality whilst add-
ing a hard anionic oxygen ligand and have selected phenolate 
because it has found wide use in many inorganic systems.30-32 
Many iridium aliphatic alkoxide systems exist although these 
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can readily undergo β-hydride elimination.33, 34 In comparison, 
phenolate ligands are more stable due to the π-interaction and 
lack of β-protons. A related system has been shown to act as a 
hydrogenation catalyst with no elimination of the phenol.35 
Here we employ a phenolate substituted NHC that can coordi-
nate to the same face of the metal to make Ir(κC,O-L1)(COD) 
(1) [where COD = cyclooctadiene and L1 = 3-(2-methylene-4-
nitrophenolate)-1-(2,4,6-trimethylphenyl) imidazolylidene] in 
order to achieve this and demonstrate good activity in non-
polar solvents whilst retaining optimal catalytic behavior. 
RESULTS AND DISCUSSION 
Synthesis and Characterization. The synthesis of Ir(κC,O-
L1)(COD) (1) via a transmetallation reaction was achieved 
according to Scheme 1. Occhipinti et al. have previously re-
ported the synthesis of the silver carbene complex AgL1
36 and 
attached it to ruthenium. Here we use a similar route to make 
1. Notably, the precursor, L1HBr in Scheme 1, shows a broad 
infrared (IR) signal at ~3000 cm−1 for a phenolic O-H stretch 
as well as signals at 1339 cm−1 and 1279 cm−1 for the O-H 
bend and C-OH stretching mode respectively.36 Complex 1 
was prepared in 96% yield and its structure confirmed by 
NMR, X-ray and mass spectrometry. A peak is present in the 
IR spectrum of 1 at 1293 cm−1 due to a C-OIr stretch. 
Scheme 1. Reaction scheme for the formation of Ir(κC,O-
L1)(COD), 1  from AgL1
36 and [Ir(COD)Cl]2
37. 
 
Comparison of the NMR data for 1 at 298 K in CD2Cl2, with 
that at 253 K revealed that its proton chemical shifts are 
strongly temperature dependent. At 298 K, the two aromatic 
proton resonances for the mesityl group appear as a broad 
singlet at δ ~7.03 but upon cooling its rotation is hindered and 
two singlets separate from it, which resonate at δ 7.06 and 
6.96. Lineshape analysis38, 39 of this behavior enabled the acti-
vation enthalpy for mesityl group rotation, ∆H≠, to be estimat-
ed as 65.5 ± 3.1 kJ mol−1 with the corresponding value for ∆S≠ 
being +28.0 ± 10.9 J K−1 mol−1. These ∆H≠ and ∆S≠ values are 
commensurate with those expected for an intramolecular ring 
rotation40, 41 (see Supplementary Information (SI) for the raw 
data). We note that similar coalescence effects are also ob-
served when 1 is present in a THF-d8 solution in accordance 
with a process where there is little charge separation.40 
In a separate dynamic process, the two proton resonances of 
the CH2 linker are also broadened, in this case into the base-
line at 298 K. At 253 K these protons provide two distinct 
doublets at δ 6.60 and 4.79 that share a common coupling of 
13.97 Hz. This behavior is a consequence of the fact that the 
two CH2 protons are diastereotopic, due to their differing exo 
and endo orientations. They become equivalent by inversion 
of the conformation of the seven-membered ring through ring-
flip and alkoxide lone pair inversion.42 The complexity of the 
associated NMR spectral changes, and the large chemical shift 
difference that exists between these resonances, precludes the 
quantitative analytical assessment of this process through line-
shape analysis. 
The structure of 1 was further confirmed by X-ray diffrac-
tion. Figure 1 shows the corresponding ORTEP plot, deter-
mined at 110 K. The crystals employed for this analysis were 
grown by the slow diffusion of hexane into a dichloromethane 
solution of 1. The crystal exhibited both pseudo-merohedral 
and multi-crystal twinning, see SI for further details. The 
structure has a distorted square planar geometry around iridi-
um where the corresponding bond angles are close to 90°. 1 
can be compared to two related Ir(I) complexes, 
Ir(IMes)(COD)(OSiMe3) containing a siloxide ligand
43 and 
[Ir(IMes)(COD)(py)]Cl containing a pyridine ligand.44 These 
complexes also proved to adopt distorted square planar ar-
rangements. 1 has an Ir-O bond length of 2.067(3) Å which 
compares well to the value of 2.020(4) Å reported for 
Ir(IMes)(COD)(OSiMe3). For [Ir(IMes)(COD)(py)]Cl the Ir-N 
bond length is 2.0954(17) Å. The C=C bond of COD which 
lies trans to the phenoxide in 1 is the longest of the series and 
hence the weakest (1.444(7) Å, compared to 1.407(5) Å for 
Ir(IMes)(COD)(OSiMe3) and 1.399(3) Å for 
[Ir(IMes)(COD)(py)]Cl). Consequently, the phenoxide ligand 
in 1 must be the most electron donating ligand of this series 
and its iridium metal center must therefore be the most elec-
tron rich. Due to this increase in electron density at iridium the 
oxidative addition of H2 to 1 will be disfavored due to repul-
sion between it and the electron density provided by the lig-
ands in the five-coordinate transition state.45 
The bond angle in 1 that exists between C(carbene)-Ir-O is 
92.88(14)° and smaller than that of C(carbene)-Ir-N (94.45(7)°) in 
[Ir(IMes)(COD)(py)]Cl. This change is a consequence of the 
chelate effect which acts here to restrict the bond angle but 
when the freely orientating complex Ir(IMes)(COD)(OSiMe3) 
is compared, the C(carbene)-Ir-OSi angle is now compressed to 
88.2(2)°. Therefore steric interactions must play a role in de-
termining the shape of these complexes. 
 
Figure 1. ORTEP plot of 1. Hydrogens have been omitted for 
clarity. Selected bond lengths (Å) and angles (°): Ir1-O1, 
2.067(3); Ir1-C8, 2.049(4); Ir1-C20, 2.111(5); Ir1-C21, 2.101(5); 
Ir1-C24, 2.185(4); Ir1-C25, 2.183(4); C20-C21, 1.444(7); C24-
C25, 1.393(7); C8-Ir1-O1, 92.88(14). 
Reactivity of 1 towards H2 or pyridine. Upon the addition 
of p-H2 at 3 bars pressure to a CD2Cl2 solution of 1 at 253 K 
an immediate reaction is observed to take place and the for-
mation of a new dihydride complex (2) is indicated (see 
Scheme 2). This species yields a pair of PHIP polarized hy-
dride resonances at δ −10.84 and −21.51 in the corresponding 
1H NMR spectrum where the chemical shift values are diag-
nostic of sites that lie trans to alkene and alkoxide respective-
ly. We note that similar spectral changes have been reported 
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when H2 adds to [Ir(COD)(NCCH3)(PMe3)]BF4 to form  
[Ir(H)2(COD)(NCCH3)(PMe3)]BF4.
46 The product of the reac-
tion with 1 is Ir(H)2(κC,O-L1)(COD) (2) and it exists in equi-
librium with 1 where a steady-state of just 5% conversion is 
achieved under these conditions. 
The very broad hydride and hydrogen signals that are seen in 
the associated 1H NMR spectra confirm that the interconver-
sion between 1 and 2 is rapid; upon heating this sample to 303 
K the hydride resonances broaden into the baseline of the 
NMR spectrum. The H2 / Ir-H exchange process that is indi-
cated by this observation provides a route to destroy the p-H2 
that is present in solution because the relaxation times of metal 
hydride ligands are relatively short.47, 48 Therefore, despite 
PHIP being observed when a sample at 243 K is removed 
from the magnet, shaken and then returned to the magnet for 
measurement this effect does not last. Furthermore, at 298 K, 
this pair of hydride signals shows very small levels of PHIP 
and appears only transiently, thereby confirming that the p-H2 
present in solution is consumed very rapidly. We note that 
significant signal averaging is necessary to observe the hy-
dride resonances of 2 with normal, thermally equilibrated 
NMR polarization. 
Scheme 2. Formation of dihydride 2 from 1. 
 
In the corresponding low temperature spectrum, a second 
pair of very weak hydride signals is observed at 243 K that 
also exhibit PHIP. These signals are only observed after a 
considerable number of scans under conditions where the 
magnetism of the molecules is thermally equilibrated. These 
new hydride ligand signals appear with just ca. 6% of the in-
tensity of those for 2 and are hence too weak to allow the as-
sociated product to be characterized. They are likely, however, 
to arise from a minor isomer of 2 that differs from the main 
isomer according to the conformation of the seven-membered 
ring. These signals do not appear in the corresponding high 
temperature NMR spectrum, presumably due to dynamic av-
eraging between the rapidly interconverting isomers. 
Upon adding pyridine to a CD2Cl2 solution of 1 the slow 
displacement of COD is indicated in the resulting 1H NMR 
spectrum. However, no clearly identifiable reaction product is 
observed in this spectrum and decomposition occurs. After 6 
days of reaction with pyridine, the subsequent addition of H2 
to the resulting solution leads to the formation of a new dihy-
dride species in 60% yield after a further 3 days of activation.  
Formation of 3 from 1 upon addition of pyridine and H2. 
In contrast, 1 reacts very slowly and cleanly with H2 when it is 
located in a freshly prepared CD2Cl2 solution containing pyri-
dine at 298 K to form the same reaction product. We have 
identified this product as neutral Ir(H)2(κC,O-L1)(py)2, 3 (see 
Scheme 3) through a series of observations that we now de-
scribe. We note that after 24 hours, 40% conversion of a 1.6 x 
10−5 mol solution of 1 with an 8-fold excess of pyridine under 
3 bars pressure of H2 to 3 is achieved; this reaction goes to 
completion on a longer timescale. 
The infrared spectrum of 3 contains a noteworthy C-O Ir 
stretch at 1274 cm−1 and no evidence for either an OH or OD 
stretch. The corresponding stretch in 1, an Ir(I) complex, is 
1293 cm−1 which suggests that the Ir(III)-alkoxide bond in 3 is 
strengthened. Furthermore, starting material 1 possesses a 
strong yellow/orange color when in solution, and this is re-
tained upon activation with pyridine and H2. UV-Vis analysis 
of 1 in CH2Cl2 reveals the complex yields an absorption band 
at 405.5 nm with a molar extinction coefficient, ε, of 21060 
dm3 mol−1 cm−1. Similar analysis of the activated complex, 3, 
reveals an absorption band at the slightly higher energy of 
398.6 nm with a reduced ε value of 10975 dm3 mol−1 cm−1. 
Interestingly, when the related complex 
[Ir(H)2(IMes)(pyridine)3]Cl is monitored in methanol, no 
equivalent transition is present, the most prominent feature 
being a broad blue shifted band at 341.0 nm with an ε of 3413 
dm3 mol−1 cm−1. The large molar absorptivity values exhibited 
by 3 are consistent with its intense color and the detection of a 
charge transfer band. 
As expected, COD is released during the formation of 3, and 
it proved to be hydrogenated on a slower timescale, first to 
form COE and then COA [where COE = cyclooctene and 
COA = cyclooctane] according to NMR analysis. The substi-
tution of COD for pyridine in a related cyclometallated square 
planar palladium system has been reported49 as has the hydro-
genation of COD in series of related systems.50-52 
Neutral 3 forms according to Scheme 3 and the alternative 
zwitterionic Ir-O bond cleaved product [Ir(H)2(κC-L1-
O−)(py)3]
+ is not observed. At 298 K, the 1H NMR spectrum of 
3 contains two distinct hydride ligands which yield a broad 
singlet at δ −21.80 for the trans pyridine site (HA) and a sharp 
doublet at δ −28.90 for the trans oxygen site (HB). Further 
analysis of these NMR spectra of 3 revealed that upon cooling 
to 223 K, each hydride signal pair separates into two sets of 
hydride resonances, at δ −21.40 (HA) and −29.80 (HB), and at 
δ −22.60 (HA’) and −29.00 (HB’) respectively with relative 
intensity 83:17. The two pairs of hydride resonances share 
common −8.9 and −7.3 Hz couplings respectively and are due 
to two conformers, 3A and 3A′, that result from differing orien-
tations of the seven-membered metallocycle. A 15N-HMQC 
2D NMR measurement completed at 233 K, located two sig-
nals at δ 258.4 and 240.7 for the equatorial and axial pyridine 
ligands of the major isomer 3A respectively. Given that the 
chemical shift of free pyridine is 303 ppm, and the difference 
between it and the bound signal has been suggested to be in-
dicative of bond strength, the ligand trans to the carbene is 
more strongly bound.53 Full characterization data for 3A at 233 
K in CD2Cl2 is presented in the SI. 
Ligand exchange pathways in Ir(H)2(κC,O-L1)(py)2, 3. 
When the hydride resonance for HA of 3 in CD2Cl2 is selec-
tively irradiated in an EXSY54 experiment at 233 K magneti-
zation transfer into only the HA’ signal of the second conform-
er is observed. The rate of this process is 4.00 ± 0.08 s−1 and 
the pair of exchanging hydride ligands remain trans to their 
original partner throughout. Probing the reverse step, by selec-
tive irradiation of HA’, enabled the rate of transfer of HA’ into 
HA to be quantified as 19.80 ± 0.33 s
−1. This means that the 
equilibrium constant connecting 3A′ and 3A is 4.95 and we note 
that it matches that determined by integration. 
Exchange of these two hydride ligands into free H2, or into a 
site that is trans to nitrogen is not observed at 233 K. The lat-
ter process, which corresponds to that of isomer interconver-
sion, is however evident at 298 K alongside that of H2 loss as 
shown in Scheme 3. In fact, the H2 loss process proved to be 
inhibited by the addition of pyridine, while the process of hy-
dride site interchange was unaffected. 
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Scheme 3. Formation of Ir(H)2(κC,O-L1)(py)2, 3, from 1 with the vacant site represented through the shaded orbital and the purple 
and magenta hydride ligand labels detailing the hydride interchange processes. 
 
 
When the corresponding 1H EXSY measurement procedure 
was used to monitor pyridine exchange in 3 only loss of the 
equatorial ligand was observed, in a process that followed 
saturation kinetics. These observations confirm that the loss of 
pyridine from 3 is therefore dissociative. Furthermore, the 
resulting 16-electron intermediate must have a trigonal bi-
pyramidal shape, or undergo very rapid hydride site inter-
change, to equilibrate hydrides HA and HB. This is reflected in 
the fact that the hydride ligand exchange process is unaffected 
by added pyridine. It can also be concluded that H2 loss from 3 
must therefore proceed after pyridine loss (see Table 1). These 
deductions are supported by the fact that the rate of H2 loss for 
a solution containing a 50-fold excess of pyridine was 0.042 ± 
0.002 s−1 whilst the corresponding pyridine loss rate was 0.28 
± 0.03 s−1. In addition, a H2 exchange mechanism based on the 
transient formation of the related complex IrCl(H)2(η
2-
H2)(PPr
i
3)2
55, 56 has been described previously. We note that 
these measurements were relatively straightforward to com-
plete in CD2Cl2 as no H/D exchange is evident on the time-
scales of these measurements. 
Table 1. Summary of the specified ligand loss rates from 3 as a 
function of pyridine concentration in CD2Cl2. Data confirms pyri-
dine loss is dissociative and that both hydride site interchange and 
H2 loss occurs after this step. 
No. of py eq. by 
NMR ratio 
Rate of py loss / s−1 Rate of H2 loss / s
−1 
15 0.28 ± 0.03 0.078 ± 0.003 
25 0.28 ± 0.03 0.071 ± 0.003 
30 0.31 ± 0.01 0.053 ± 0.002 
50 0.28 ± 0.03 0.042 ± 0.002 
 
When examined in MeOD-d4, 1 still reacts with H2 and pyri-
dine to form 3 in an analogous way to that described in 
CD2Cl2. The hydride ligand resonances of 3 appear at δ 
−21.62 and −29.22 in this solvent and are hence very similar 
in value to those in CD2Cl2. In this case, 100% conversion of a 
7.9 x 10−6 mmol solution of 1 is observed after just 24 hours 
and thus the activation of 1 is much more facile in this polar 
protic solvent when compared to CD2Cl2. At 243 K, H/D ex-
change between the hydrides and the solvent is not observed. 
However, at 270 K, deuterium exchange from the solvent into 
the hydride resonances of 3 proceeds with an experimentally 
determined rate constant of 4.24 x 10−5 ± 6 x 10−7 s−1 and both 
HD and MeOH-d3 are formed. At 298 K, the rate constant for 
H/D exchange increases to 8.19 x 10−4 ± 8 x 10−6 s−1. 
In order to examine the pyridine and H2 exchange processes 
more reliably, the solvent MeOH-d3 was employed. At 298 K, 
a sample containing 15 eq. of pyridine enabled the observation 
that the hydride ligand trans to the oxygen donor proved to 
exchange into H2 with an experimentally determined rate con-
stant of 0.54 ± 0.03 s−1, a ∆H≠ of 67.5 ± 7 kJ mol−1 and a ∆S≠ 
of −17.3 ± 25 J K−1 mol−1. In contrast, pyridine dissociation at 
298 K occurs with a rate constant of 1.33 ± 0.23 s−1, a ∆H≠ of 
71.1 ± 3 kJ mol−1 and a ∆S≠ of 2.4 ± 12 J K−1 mol−1. In MeOH-
d3, H2 loss therefore proceeds at a slower rate than pyridine 
loss and upon increasing the number of equivalents of pyri-
dine, the rate of H2 loss is decreased, whilst the rate of pyri-
dine loss remained constant. This is again consistent with the 
mechanism shown in Scheme 3 and shows that the exchange 
process remains dissociative in methanol. A mechanism for 
such an H/D exchange process in a closely related system has 
been proposed by Brookhart et al.57, 58 
Reaction of 3 with p-H2. Upon addition of p-H2, to a 
CD2Cl2 solution of 1 at 298 K, a single pair of PHIP enhanced 
hydride signals are observed that are indicative of 3.59 The 
enhanced signal at δ −28.90 that is due to the HB hydride lig-
and of 3 and which lies trans to oxygen, has a line-width at 
half height of 14.6 Hz and signal integration confirms a signal 
enhancement of 346-fold relative to that seen in the normal 
trace. Its partner appears at δ −21.40 with a half-height width 
of 45.1 Hz. When the same measurement is made at 268 K or 
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below, neither the hydride resonances of 3A or 3A′ show PHIP 
in accordance with the suppression of their exchange with the 
free H2 pool. 
In order to test for the formation of zwitterionic [Ir(H)2(κC-
L1-O
−)(py)3]
+ we have also examined the formation of 3 when 
a 1:1 mixture of d5- and h5-pyridine is employed. Under these 
conditions no new PHIP enhanced hydride ligand signals are 
seen even though related studies on 
[Ir(H)2(IMes)(pyridine)3]Cl would suggest that the presence of 
the 2H-label is sufficient to break hydride ligand symmetry 
and thereby enable it to exhibit PHIP. For these reasons we 
conclude that the Ir-O bond in 3 is retained throughout these 
measurements in CD2Cl2. Analogous results are observed 
when the solvent is changed to methanol-d4 so again the Ir-O 
bond is retained. 
Solvent effects on SABRE catalysis by 3. Evidence for the 
SABRE effect is also seen in many of the 1H NMR signals 
that are observed in these NMR spectra. The simplest experi-
mental procedure to view the SABRE effect involves taking 
an NMR tube under an atmosphere of p-H2 and shaking it for a 
set time period in a known magnetic field before rapidly mak-
ing an NMR observation. We now describe the results of this 
process in the solvents CD2Cl2, benzene-d6, THF-d8, metha-
nol-d4 and ethanol-d6. We discuss the catalyst activation pro-
cess and highlight the species that are formed. Table 2 details 
the performance of 1 under SABRE in the indicated solvents 
after 2 and 24 days respectively. The hydride ligand that is 
trans to oxygen in 3 always gives rise to a sharp doublet in 
these 1H NMR spectra while the resonance for the hydride 
ligand that lies trans to pyridine is considerably broader. This 
suggests that pyridine loss is possible in accordance with the 
observations we described earlier in the manuscript. 
When a sample containing 0.05 M pyridine and 15 mol% 1 
in CD2Cl2 is examined in this way, after polarization transfer 
in a 6.5 x 10−3 T field, strong SABRE is visible in the NMR 
signals observed for free pyridine that is present in solution. 
This effect manifests itself clearly in the resulting single scan 
1H NMR measurement as a 141-fold enhanced ortho pyridine 
proton resonance when compared to the corresponding signal 
without polarization transfer. We note that complex 3 is de-
tected as the sole inorganic reaction product in these solutions 
for periods out to 24 days and that no deuterium exchange 
with the solvent is evident. 
3 also forms cleanly in both benzene-d6 and THF-d8 solu-
tions where it is again stable for extended periods of time. We 
observed, however, that the slow reaction means that signifi-
cant time is necessary for full activation. When a benzene-d6 
system is examined for SABRE, after 2 days of activation, a 
121-fold signal enhancement is seen for the same ortho pyri-
dine proton signal under similar conditions. In THF-d8 the 
analogous level of signal gain reduces to 98-fold for a similar 
sample under similar conditions. Despite this drop in SABRE 
efficiency in THF-d8, these observations in CD2Cl2, benzene-
d6 and THF-d8, confirm our original hypothesis that neutral 3 
is a good SABRE catalyst in a variety of low polarity solvents. 
When the same systems are examined after 24 days the signal 
enhancements for the ortho protons of pyridine in these sam-
ples have now increased to a maximum of 346-fold, 561-fold 
and 600-fold for CD2Cl2, benzene-d6 and THF-d8 respectively. 
This information confirms that while the catalyst takes longer 
to fully form in these less polar solvents it delivers good activ-
ity. 
Table 2. Pyridine 1H NMR signal enhancements produced for a 
series of 0.05 M pyridine and 15 mol% 1 solutions at 298 K using 
3 bars of p-H2 after an activation period of 48 hours and 24 days. 
Deuterated 
solvent 
Pyridine 1H NMR SABRE signal enhancements 
(fold) 
48 hours 24 days 
 ortho meta para ortho meta para 
Benzene 121 93 56 561 469 253 
THF 98 61 49 600 442 265 
DCM 141 105 65 346 212 159 
Ethanol 86 35 36 282 145 142 
Methanol 185 130 82 29 24 18 
 
When the solvent is changed to polar protic methanol or eth-
anol different behavior is observed. In MeOD-d4 for a sample 
containing 0.1 M pyridine and 5 mol% 1, the initial levels of 
SABRE that were observed in the 1H NMR resonances of 
pyridine are small (~6 fold for the ortho 1H resonances) after 
shaking in a polarization transfer field (PTF) of 6.5 x 10−3 T at 
40°C. However, when the same sample is tested 72 hours lat-
er, the signal enhancement levels are far greater (178, 96, 52 
fold observed for ortho, meta and para 1H resonances of pyri-
dine respectively). A typical trace is shown in Figure 2. These 
data confirm our earlier observation that 1 takes a significant 
time to fully activate. However, upon longer time scales, the 
level of delivered polarization falls as the pyridine substrate 
becomes 2H-labelled; 50% deuteration of the ortho proton 
signal for pyridine was observed after 24 days in methanol-d4. 
The analogous deuterium exchange process is seen in ethanol-
d6, but it now proceeds more slowly in accordance with the 
slower formation of 3; no deuterium exchange is seen in the 
non-protic solvents. 
 
Figure 2. 1H NMR spectra of a sample containing 0.05 M pyri-
dine and 15 mol% 1 in MeOD-d4 after; (A) thermal equilibrium at 
high field; and (B) polarization transfer from p-H2 at 6.5 x10
−3 T, 
using a 45° pulse. Pyridine and hydride species are labelled. 
In order to demonstrate that the polarization transfer to pyri-
dine observed in these systems arises from SABRE rather than 
one-proton PHIP, a d5-pyridine containing solution was also 
examined. These measurements were completed after shaking 
the sample in a PTF of 6.5 x 10−3 T and involved the applica-
tion of a 45° excitation pulse. The 1H NMR signal for residual 
d4-pyridine was shown to polarize, delivering an in-phase 
emission peak at δ 8.56 which rapidly decayed to thermal 
magnetization over a time course of ~30 s. If this signal was to 
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be enhanced through the one-proton PHIP effect it should 
remain enhanced over this period. For this reason we conclude 
that SABRE is the only polarization transfer pathway operat-
ing.60, 61 
The magnetization transfer process was also probed by 
OPSY (Only Parahydrogen SpectroscopY62, 63). This pulse 
sequence enables the detection of signals that are either de-
rived directly from p-H2 or nuclei that have received polariza-
tion from it. Two representative 1H NMR spectra that were 
recorded after shaking in a PTF of 2 x 10−4 T at  0°C or 60°C 
respectively are shown in Figure 3. It can be readily seen from 
these NMR spectra that greater polarization transfer is evident 
at 60°C and that polarization transfer via SABRE into free 
pyridine occurs. The two NMR spectra are presented in mag-
nitude mode and the signals for pyridine and the hydride reso-
nances of 3 dominate which confirms that they receive visible 
polarization from p-H2.. 
 
Figure 3. 1H OPSY-dq NMR spectra of a sample containing 0.1 
M pyridine and 5 mol% 1 in MeOD-d4 after polarization transfer 
from p-H2 at 2 x 10
−4 T and 60°C (A) or 0°C (B). 
SABRE catalysis optimization using 3. In order to opti-
mize the efficiency of polarization transfer in methanol from 
p-H2 to substrates using 1 a number of conditions have been 
investigated. These include varying the temperature, the PTF 
and the catalyst. The most widely used catalyst to date is 
IrCl(IMes)(COD), 4.64,15 When activated with pyridine and H2, 
4 has been reported to form [Ir(H)2(IMes)(py)3]Cl which then 
enables polarization transfer. The route to H2 addition to 4 is 
via the formation of [Ir(IMes)(COD)(py)]Cl which actually 
adds H2 faster than the precursor IrCl(IMes)(COD). In con-
trast, 1 takes a significant time to activate due to the analogous 
indirect reaction pathway being no longer available because of 
the strong Ir-O bond.  
Table 3 displays a series of enhancement data that results 
from the SABRE of the substrates pyridine and nicotinamide 
in MeOD-d4 as a function of temperature and transfer field 
using both 4 and 1. It is clear from this table that 4 is the supe-
rior room temperature catalyst, delivering in some instances 
30 times more signal intensity when compared to that pro-
duced by 1. For 1, the signal enhancement seen for bulk nico-
tinamide proton HA increases by  a factor of ~5 on going from 
2 x 10−4 T to 6.5 x 10−4 T at 30°C, and a factor of ~6 at 60°C. 
This compares with a drop in signal intensity when 4 is em-
ployed at the higher temperatures. Now, under transfer at 6.5 x 
10−4 T, proton HA of nicotinamide shows better enhancement 
at 30°C rather than 60°C. These investigations on nicotina-
mide were conducted because of the recent publications which 
investigate the biological implications of hyperpolarizing 
nicotinamide in a move towards developing imaging applica-
tions that utilize the SABRE technique.17-19, 21 
Table 3. Signal enhancements obtained for each of the listed 1H 
resonances of pyridine and nicotinamide after polarization trans-
fer in fields of either 2 x 10 −4 T or 6.5 x 10−3 T using catalyst 1 or 
4 in MeOD-d4. For proton assignments see the SI. 
 Polarization transfer  
at 2 x 10−4 T 
Polarization transfer  
at 6.5 x 10−3 T 
 1 4 1 4 
1H resonance 30°C 60°C 30°C 60°C 30°C 60°C 30°C 60°C 
Pyridine 
HA, HE 
44 72 616 269 116 254 677 474 
Pyridine 
HB, HD 
20 20 188 35 70 158 182 212 
Pyridine 
HC 
10 20 247 113 28 66 295 205 
Nicotinamide 
HA 
4 7 147 117 20 40 469 393 
Nicotinamide 
HB 
2 2 74 59 15 33 306 242 
Nicotinamide 
HC 
2 4 99 54 6 18 64 55 
Nicotinamide 
HD 
3 5 107 85 20 40 364 293 
 
The effect of temperature is also clearly illustrated in Figure 
4. The continued improvement in the activity of 1 with an 
increase in temperature is associated with an increase in ligand 
dissociation rate.15 In contrast, the rate of ligand exchange with 
4 actually becomes too rapid for good catalysis upon exceed-
ing 30°C. A full comparison of temperature dependent 1H 
NMR enhancements for pyridine and nicotinamide in MeOD-
d4 as polarized by 1 and 4 is detailed in the SI. 
 
Figure 4. Normalized enhancement of the HA 
1H NMR resonance 
of nicotinamide after polarization transfer at 6.5 x 10−3 T using 
either 1 (▲) or 4 (●). 
Further optimization was achieved by altering the PTF. This 
study was completed  using a polarizer equipped with a verti-
cally aligned coil that is capable of producing a well-defined 
vertical field between 0.5 x 10−4 T and ±1.5 x 10−2 T in steps 
of 0.5 x 10−4 T.15, 18 The four hyperpolarized 1H resonances of 
nicotinamide resulting from polarization in set fields between 
−1.5 x 10−2 T and +2.5 x 10−3 T are illustrated in Figure 5. The 
maximum signal enhancement proved to be delivered by 1 
when the PTF lies between −6.5 x 10−3 T and −7.5 x 10−3 T for 
sites HA, HB and HC and their signals all appear in emission. 
The corresponding meta proton (HC) resonance undergoes two 
phase changes on moving from −1.5 x 10−2 T to −1.25 x 10−2 
T and −6.5 x 10−3 T to −5.0 x 10−3 T respectively, and shows 
relatively weak signal amplification levels. Related observa-
tions have been reported for pyridine with 4 and the profiles 
are remarkably similar even though the two catalysts are very 
different in their nature.13 
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Figure 5. 1H NMR field plots showing the signal intensity of the four 1H (A-HA, B-HD, C-HB, D-HC) resonances of nicotinamide over the 
range of −1.5 x 10−2 T to +2.5 x 10−3 T. 
Two other substrates that have been shown to polarize using 
4 for SABRE in methanol include quinoline65 and nicotine.21 
We have therefore examined these substrates using 1 in ben-
zene as this is one of the most efficient solvent systems for 
this neutral catalyst. Both compounds show enhanced signals, 
with polarization transfer to nicotine being more efficient than 
quinolone. Nicotine exhibits a total proton enhancement of 
360-fold across the four aromatic proton sites with quinolone 
showing a 54-fold increase across six of its proton sites. This 
shows that the use of specially designed catalysts in non-polar 
solvents could prove very important for identifying low con-
centration analytes in solution via the SABRE approach. 
CONCLUSIONS 
The iridium precatalyst Ir(κC,O-L1)(COD) (1) which con-
tains a phenolate substituted NHC has been synthesized and 
shown to act as a SABRE catalyst precursor in the five sol-
vents, dichloromethane, benzene, tetrahydrofuran, methanol 
and ethanol. This overcomes the current low polarity solvent 
limitations shown by existing SABRE catalysts. 1 contains 
strong Ir-O and Ir-NHC bonds which are preserved in all of 
these solvents and the chelate effect acts to create a seven-
membered metallocycle that adopts two interconverting con-
formations in solution because of the non-linearity of the Ir-O-
C bond. In addition, the square planar catalyst precursor 1, 
exhibits a strong charge transfer transition at 398 nm. 
We have shown that 1 and H2 exist in equilibrium with di-
hydride 2 at low temperature in CD2Cl2 solution. The hydride 
resonances of this product exhibit PHIP in the associated 1H 
NMR spectra. 2 is an example of an unusual M(H)2(alkene) 
intermediate, for which other related complexes have been 
implicated in hydrogenation catalysis in many systems.66, 67 
Upon warming 1 in the presence of pyridine and H2 in the five 
described solvents, slow conversion into neutral 3, 
Ir(H)2(κC,O-L1)(py)2 is observed. The stepwise hydrogenation 
of COD, first into COE and then COA is also evident upon 
studying this reaction at 298 K. 
Neutral 3 has been shown to undergo the dissociative loss of 
pyridine, according to Scheme 3, prior to H2 exchange but no 
evidence for the reductive elimination of the cis IrO and IrH 
groups is observed even though the corresponding alcohol 
would be expected to be stable. The pyridine and H2 ligand 
loss processes enables the incorporation of p-H2 into 3 and 
thereby facilitates its action as a good SABRE catalyst. 
In methanol, the formation of 3 proceeds cleanly with no ev-
idence being observed for zwitterionic [Ir(H)2(κC-L1-
O−)(py)2(CD3OD)]
+  or  [Ir(H)2(κC-L1-O
−)(py)3]
+ in solution. 
The ligand exchange rates for substrate dissociation and H2 
loss have been determined in MeOH-d3, and both increase 
with temperature. The H2 loss process has been suggested to 
proceed via Ir(H)2(H2)(κC,O-L1)(py) as shown in Scheme 3. 
The associated activation parameters for the H2 loss process, 
∆H≠ and ∆S≠ are 67.5 ± 7 kJ mol−1 and −17.3 ± 25 J K−1 mol−1 
respectively.  In contrast, pyridine dissociation which precedes 
H2 loss occurs with a ∆H
≠ of 71.1 ± 3 kJ mol−1 and a ∆S≠ of 
2.4 ± 12 J K−1 mol−1. The entropy term for this latter reaction 
is smaller than expected for a dissociative exchange pathway 
and may reflect an early transition state or a reduction in the 
conformational freedom of the seven-membered ring. 
Nevertheless, when 3 is monitored for activity as a polariza-
tion transfer catalyst good levels of hyperpolarization are seen 
in a range of substrates when utilizing the low polarity sol-
vents, CD2Cl2, benzene-d6 and THF-d8 that find widespread 
use in NMR spectroscopy. For example, in THF, the ortho 
proton of the substrate pyridine shows an impressive 600-fold 
enhancement which equates to 2% polarization level. Fur-
thermore, the level of PTC was found to be PTF dependent, 
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and in methanol, the best single spin polarization resulted 
from transfer at a field strength of between −6.5 x 10−3 T and 
−7.5 x 10−3 T. When PTC by 3 in methanol is compared to 
that achieved by [Ir(H)2(IMes)(py)3]Cl, whilst lower catalyst 
efficiency is observed, the enhancement levels are still com-
mensurate with significant time savings in both NMR and 
MRI measurements. Superior catalysis is, however, found in 
benzene using 1 and similar signal enhancements are seen in 
dichloromethane albeit with a different catalyst species present 
to that described previously for 4. 
The range of substrates exemplified includes pyridine, quin-
oline and nicotine in order to demonstrate the wider utility of 
this catalyst in non-polar solvents. We note that catalyst acti-
vation takes on average 5 days in these relatively non-polar 
solvents but over 500-fold ortho proton enhancement values 
for pyridine result. These enhancement levels can be improved 
further still by warming and using an optimized PTF. We 
therefore expect derivatives of this neutral catalyst to dramati-
cally widen the applicability of SABRE for NMR measure-
ments in the future, and we are now seeking to prepare a 
precatalyst such as Ir(κC,O-L1)(COE)2 which may activate 
rapidly whilst retaining both the air stability and efficiency of 
1. 
EXPERIMETNAL PROCEEDURES 
Methods and equipment. All experimental procedures 
were performed under an atmosphere of either dinitrogen or 
argon, using standard Schlenk line techniques or an MBraun 
Unilab glovebox, unless otherwise stated. General solvents for 
synthetic chemistry were dried using an Innovative Technolo-
gy anhydrous solvent engineering system or were distilled 
from an appropriate drying agent under N2 as necessary. Deu-
terated solvents (methanol- d4, methanol- d3, CDCl3, CD2Cl2, 
benzene- d6, THF- d8) were obtained from Sigma-Aldrich and 
Cambridge Isotope Laboratories (ethanol- d6) and used as 
supplied. NMR measurements were made on a Bruker Avance 
III series 400 MHz NMR spectrometer (1H at 400.13 MHz, 
13C at 100 MHz) and a 500 MHz NMR spectrometer (1H at 
500.13 MHz, 13C at 125.77 MHz). NMR samples were made 
up in Young’s tap equipped 5 mm NMR tubes. Parahydrogen 
(p-H2) was prepared by cooling hydrogen gas over charcoal in 
a copper block at 30 K. COSY, HMQC and EXSY54 pulse 
sequences were used as previously described. Polarization 
transfer experiments are described in the supplementary. 
X-ray. Single crystals of C27H30Ir1.04N3O3 (1) were grown 
from slow diffusion of hexane into a DCM solution of 1. A 
suitable crystal was selected and diffraction data were collect-
ed at 110 K on an Oxford Diffraction SuperNova diffractome-
ter with Cu-Kα radiation (λ = 1.54184 Å) using an EOS CCD 
camera.  The crystal was cooled with an Oxford Instruments 
Cryojet. Diffractometer control, data collection, initial unit 
cell determination, frame integration and unit-cell refinement 
was carried out with “Crysalis” (CrysAlisPro, Oxford Diffrac-
tion Ltd. Version 1.171.34.40). Face-indexed absorption cor-
rections were applied using spherical harmonics, implemented 
in SCALE3 ABSPACK scaling algorithm (Empirical absorp-
tion correction using spherical harmonics, implemented in 
SCALE3 ABSPACK scaling algorithm within CrysAlisPro 
software, Oxford Diffraction Ltd. Version 1.171.34.40). 
OLEX268 was used for overall structure solution, refinement 
and  preparation of computer graphics and publication data.  
Within OLEX2, the algorithm used for structure solution was 
direct methods,69 within SHELXS.  Refinement by full-matrix 
least-squares used the SHELXL algorithm within OLEX2. All 
non-hydrogen atoms were refined anisotropically.  Hydrogen 
atoms were placed using a “riding model” and included in the 
refinement at calculated positions. 
The crystal exhibited both merohedral and multi-crystal 
twinning.  Only one form of twinning can be modelled.  Mod-
elling the merohedral twinning gave a statistically better result 
than the multi-crystal twin model.  For the merohedral twin-
ning, a twin matrix of -1 0 0  0 -1 0  0 0 1 was used with a 
BASF of 0.0863(5).  This left large residual density of 8 e Å-3 
presumably due to the alternative site of iridium from the mul-
ti-crystal twinning.  This was accounted for by adding a par-
tially occupied iridium with a refined occupancy of 
0.0418(12), all other atoms from this minor form were too 
weak to be modelled.  Inclusion of the partial iridium gave a 
significant improvement in the structure quality (R1 [I>=2σ 
(I)] from 4.22 to 3.45%, wR2 [All data] from 10.06 to 7.01%, 
residual density from 8.08 to 1.81 e Å-3). 
Synthesis of 1-(2,4,6-trimethylphenyl)-1H-imidazole.
70 
Glacial acetic acid (10 ml), aqueous formaldehyde (3 ml, 37 
wt %, 40 mmol) and aqueous glyoxal (4.6 ml, 40 wt %, 40 
mmol) were added to a round bottom flask and heated at 70°C. 
A solution of glacial acetic acid (10 ml), ammonium acetate 
(3.08 g, 40 mmol, in 2 ml water) and mesitylamine (5.6 ml, 40 
mmol) was added dropwise to the flask over a period of 30 
min. The resulting solution was continuously stirred and heat-
ed for 18 h. The reaction mixture was cooled to room tempera-
ture and was added dropwise to a stirred solution of sodium 
hydrogen carbonate (29.4 g in 300 ml water). The product 
formed a precipitate which was filtered off and washed with 
water before being allowed to air dry. The brown solid was 
dissolved in the minimal amount of ethyl acetate and placed in 
a freezer o/n whereupon the required product crystallised and 
was isolated via filtration (4.36 g, yield 59 %); 1H NMR 
[CDCl3, 400 MHz] δ 7.44 (s, 1H, CHimidazole), 7.24 (s, 1H, 
CHimidazole), 6.98 (s, 2H, 2xCHmesityl), 6.90 (s, 1H, CHimidazole), 
2.35 (s, 3H, CH3), 2.00 (s, 6H, 2xCH3); 
13C{1H} NMR 
[CDCl3] δ 138.8, 137.5, 135.4, 133.4, 129.5, 129.0, 120.1, 
21.0 (CH3), 17.3 (2xCH3); MS [ESI] m/z 187.0 (M+H)
+ 
Synthesis of 3-(2-methylene-4-nitrophenol)-1-(2,4,6-
trimethylphenyl) imidazolium bromide, L1HBr.
36 1-(2,4,6-
trimethylphenyl)-1H-imidazole (0.61 g, 3.3 mmol) and 2-
hydroxy-5-nitrobenzyl bromide (0.76 g, 3.3 mmol) were dis-
solved in toluene (8 ml). The resulting mixture was refluxed 
for 18 h and then the solution was cooled to room temperature. 
The precipitate was collected via vacuum filtration and was 
washed with diethyl ether (1.25 g, yield 91 %); 1H NMR 
[DMSO, 400 MHz] δ 11.81 (s, 1H, OH), 9.55 (s, 1H, CHimidaz-
ole), 8.39 (d, 1H, 
4
J(HH) = 2.55 Hz, CHaromatic), 8.22 (dd, 1H, 
4
J(HH) = 2.55 Hz, 3J(HH) = 9.04 Hz, CHaromatic), 8.05 (s, 1H, 
CHimidazole), 7.94 (s, 1H, CHimidazole), 7.15 (s, 2H, 2xCHmesityl), 
7.09 (d, 1H, 3J(HH) = 9.04 Hz, CHaromatic), 5.53 (s, 2H, CH2), 
2.33 (s, 3H, CH3), 2.01 (s, 6H, 2xCH3);
 13C{1H} NMR 
[DMSO, 500 MHz] δ 163.3 (Caromatic), 141.2 (Caromatic), 140.3 
(Caromatic), 139.1 (CHimidazole), 135.2 (Caromatic), 132.0 (Caromatic), 
130.1 (2xCHmesityl), 128.1 (CHaromatic), 127.9 (CHaromatic), 125.0 
(CHimidazole), 124.1 (CHimidazole), 122.2 (Caromatic), 116.7 (CHaro-
matic), 49.2 (CH2), 21.5 (CH3), 17.7 (2xCH3); MS [ESI] m/z 
338.1 (M-Br)+ 
Synthesis of silver(II) 3-(2-methylene-4-nitrophenolate)-
1-(2,4,6-trimethylphenyl)imidazolylidene, AgL1.
36
 L1 (500 
mg, 1.2 mmol), silver (I) oxide (569.4 mg, 2.5 mmol) and 4Å 
molecular sieves (1.12 g) were added to a Schlenk flask under 
a nitrogen atmosphere. Dried THF (8.5 ml) and toluene (8.5 
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ml) were added to the flask and the reaction mixture was 
stirred at reflux for 3 h. Once cooled to room temperature, the 
mixture was diluted with dichloromethane (80 ml), filtered 
through a pad of celite and washed through with dichloro-
methane (2 x 5 ml). The solvent was removed under pressure 
to produce a yellow solid (0.45 g, yield 85%); 1H NMR 
[CDCl3, 400 MHz] δ 8.16 (s br, 1H, CHaromatic), 7.78 (s br, 1H, 
CHaromatic), 7.38 (s br, 1H, CHaromatic), 7.01 (s br, 2H, 
2xCHmesityl), 6.99 (s br, 1H, CHaromatic), 5.84 (s br, 1H, CHaro-
matic), 5.27 (s br, 2H, CH2), 2.42 (s, 3H, CH3), 1.96 (s br, 6H, 
2xCH3); 
13C{1H} NMR [CDCl3] δ 174.7, 139.6, 137.2, 135.2, 
134.5, 129.2 (2xCHmesityl), 127.2 (CHaromatic), 126.8 (CHaromatic), 
124.4, 122.2, 121.9 (CHaromatic), 121.5 (CHaromatic), 50.3 (CH2), 
21.4 (CH3), 17.9 (2xCH3); MS [ESI] m/z 783 (Ag dimer, pro-
tonated phenol groups) 
Synthesis of iridium(I) (3-(2-methylene-4-
nitrophenolate)-1-(2,4,6-trimethylphenyl)imidazolylidene) 
(cyclooctadiene), 1.
37 AgL1 (170 mg, 0.38 mmol) and 
[Ir(COD)Cl]2 (129 mg, 0.19 mmol) were added to a Schlenk 
flask, which was evacuated and filled with nitrogen. Dry THF 
(12 ml) was added to the flask and the reaction mixture was 
stirred overnight at room temperature. The mixture was dilut-
ed with DCM, filtered through a pad of celite then purified by 
column chromatography (silica, DCM:acetone 80:20). It was 
evaporated to dryness to produce an orange/brown powder 
(0.23 g, yield 96 %); 1H NMR [CD2Cl2, 500 MHz, 298 K] δ 
8.17 (d, 1H, 4J(HH) = 3.05 Hz, CHaromatic), 7.96 (dd, 1H, 
4
J(HH) = 3.05 Hz, 3J(HH) = 9.28 Hz, CHaromatic), 7.14 (d, 1H, 
3
J(HH) = 1.94 Hz, CHimidazole), 7.03 (s, br, 2H, 2xCHmesityl), 
6.72 (d, 1H, 3J(HH) = 1.94 Hz, CHimidazole), 6.60 (s v. br, 1H, 
CH2 linker), 6.57 (d, 1H, 
3
J(HH) = 9.28 Hz, CHaromatic), 4.79 (s 
v. br, 1H, CH2 linker), 4.40 (s, v. br, 2H, 2xCHCOD), 3.30 (s v. 
br, 1H, CHCOD), 2.45 (s v. br, 1H, CHCOD), 2.39 (s, 3H, CH3), 
2.09 (s br, 4H, CH2 COD), 2.03 (s br, 6H, 2xCH3), 1.58 (s br, 
4H, CH2 COD);
 1H NMR [CD2Cl2, 500 MHz, 253 K] δ 8.18 (d, 
1H, 4J(HH) = 3.01 Hz, CHaromatic), 7.96 (dd, 1H, 
4
J(HH) = 3.01 
Hz, 3J(HH) = 9.24 Hz), 7.14 (d, 1H, 3J(HH) = 1.87 Hz, CHimid-
azole), 7.06 (s, 1H, CHmesityl), 6.96 (s, 1H, CHmesityl), 6.72 (d, 1H, 
3
J(HH) = 1.87 Hz, CHimidazole), 6.60 (d, 1H, 
2
J(HH) = 14.02 
Hz, CH2 linker), 6.55 (d, 1H, 
3
J(HH) = 9.24 Hz, CHaromatic), 
4.79 (d, 1H, 2J(HH) = 14.02 Hz, CH2 linker), 4.42 (m, 1H, 
CHCOD), 4.26 (m, 1H, CHCOD), 3.27 (m, 1H, CHCOD), 2.41 (m, 
1H, CHCOD), 2.36 (s, 3H, CH3), 2.20 – 2.00 (m, 4H, 2xCH2 
COD), 2.07 (s, 3H, CH3), 1.96 (s, 3H, CH3), 1.68 – 1.53 (m, 4H, 
2xCH2 COD); 
13C{1H} NMR [CD2Cl2, 500 MHz, 253 K] δ 
175.7 (C-OIr), 175.1 (C-Ir), 139.0 (Caromatic), 136.1 (Caromatic), 
135.5 (Caromatic), 134.4 (Caromatic), 134.0 (Caromatic), 129.1 (CHaro-
matic), 128.4 (CHaromatic), 127.0 (CHaromatic), 126.3 (CHaromatic), 
123.4 (CHimidazole), 123.2 (Caromatic), 121.5 (CHaromatic), 119.6 
(CHimidazole), 84.7 (CH), 84.6 (CH), 51.2 (CH2), 49.7 (CH), 
48.3 (CH), 34.5 (CH2), 33.8 (CH2), 28.9 (CH2), 28.4 (CH2), 
21.0 (CH3), 18.7 (CH3), 17.6 (CH3); MS [ESI] m/z 636.19. 
Anal. Calcd for C27H30N3O3Ir (Mr = 636.77): C, 50.93; H, 
4.75; N, 6.60. Found: C, 50.64; H, 4.52; N, 6.14. 
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